Agentic Spatial Pathologist Commercialization Plan#

This document outlines a practical way to commercialize spatho while keeping a strong academic and non-commercial entry point.

Reference Pattern: CyteType#

CyteType is a useful benchmark because it separates free academic access from paid commercial access instead of forcing a single licensing mode.

Public documentation currently states:

  • academic and non-commercial use is free

  • free use is capped at three annotation runs per day

  • users can also bring their own LLM API keys or run local models

  • commercial use is licensed with an annual fee plus a usage-based fee

  • enterprise options include isolated or on-prem deployments

Reference:

Why This Split Fits Spatial Pathologist#

Unlike a purely algorithmic library, spatho has a real marginal cost when users rely on managed LLM inference. That means a good product split is:

  • free software for academic self-service users

  • paid convenience, governance, support, and managed inference for commercial users

This avoids blocking academic adoption while still creating a business model.

Concrete Product Recommendation#

The cleanest product packaging is:

  • spatho Community Edition Local package and CLI, non-commercial, BYO API key or local models.

  • spatho Commercial Licensed commercial build and support, optional managed OpenAI billing, optional hosted collaboration layer.

  • spatho Enterprise Private deployment, customer-managed credentials, governance and security controls.

Suggested Next Business Steps#

  1. Keep the local CLI and organ-pack workflow public and non-commercial.

  2. Add provider abstraction so commercial customers can choose managed inference or BYO key.

  3. Add token and job metering at the case, cluster, and structure-review levels.

  4. Add authenticated report storage and organization-level access control.

  5. Define a commercial license and order form separate from the public repo license.